Annual Results Results Snapshot
Figures in Rs cr
Consolidate Annual Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Net Sales
2,177.41
1,852.14
1,490.84
1,376.18
1,134.21
1,000.07
912.69
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,177.41
1,852.14
1,490.84
1,376.18
1,134.21
1,000.07
912.69
Raw Material Cost
667.70
612.97
540.67
419.76
371.33
412.06
348.66
Purchase of Finished goods
444.28
314.78
163.25
311.57
120.60
105.85
153.92
(Increase) / Decrease In Stocks
-73.86
-6.39
12.90
-136.28
52.95
-19.90
20.55
Employee Cost
293.64
239.37
220.30
197.32
168.42
159.07
147.75
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.01
0.00
-0.01
163.44
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
387.07
352.09
294.84
244.20
228.66
210.86
0.00
Total Expenditure (Excl Depreciation)
1,718.83
1,512.82
1,231.96
1,036.58
941.96
867.93
834.31
Operating Profit (PBDIT) excl Other Income
458.58
339.32
258.88
339.60
192.25
132.14
78.38
Other Income
50.42
59.31
41.85
6.69
0.33
4.62
8.47
Operating Profit (PBDIT)
509.00
398.63
300.73
346.29
192.58
136.76
86.86
Interest
11.20
9.13
8.45
7.99
8.75
9.66
10.22
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
497.80
389.50
292.28
338.30
183.83
127.10
76.64
Depreciation
74.27
51.85
44.78
36.15
26.66
22.80
26.84
Profit Before Tax
423.53
337.65
247.51
302.16
157.17
104.31
49.80
Tax
108.63
72.33
60.70
63.63
36.42
23.87
14.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
314.90
265.32
186.81
238.54
120.75
80.44
35.80
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
314.90
265.32
186.81
238.54
120.75
80.44
35.80
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-1.20
0.99
-2.25
0.00
0.00
0.00
-2.86
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
313.70
266.31
184.57
238.54
120.75
80.44
32.94
Equity Capital
45.32
45.32
40.93
40.93
40.93
40.93
40.93
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,019.74
1,699.85
1,161.34
845.56
595.08
501.55
0.00
Earnings per share (EPS)
6.92
5.88
4.51
5.83
2.95
1.97
0.8
Diluted Earnings per share
6.92
6.41
4.51
5.76
2.86
1.87
0.8
Operating Profit Margin (Excl OI)
21.06%
18.32%
17.36%
24.68%
16.95%
13.21%
8.59%
Gross Profit Margin
22.86%
21.03%
19.61%
24.58%
16.21%
12.71%
8.4%
PAT Margin
14.46%
14.33%
12.53%
17.33%
10.65%
8.04%
3.92%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2024 is 17.56% vs 24.23% in Mar 2023
Consolidate Net Profit
YoY Growth in year ended Mar 2024 is 17.80% vs 44.29% in Mar 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2024 is 35.15% vs 31.07% in Mar 2023
Interest
YoY Growth in year ended Mar 2024 is 22.67% vs 8.05% in Mar 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2024 has improved from Mar 2023
Compare Annual Results Of Marksans Pharma With
Figures in Rs cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
2,177.41
10,334.77
-8,157.36
-78.93%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,177.41
10,334.77
-8,157.36
-78.93%
Raw Material Cost
667.70
1,853.52
-1,185.82
-63.98%
Purchase of Finished goods
444.28
1,409.85
-965.57
-68.49%
(Increase) / Decrease In Stocks
-73.86
-53.67
-20.19
-37.62%
Employee Cost
293.64
2,274.73
-1,981.09
-87.09%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
387.07
2,315.28
-1,928.21
-83.28%
Total Expenditure (Excl Depreciation)
1,718.83
7,799.71
-6,080.88
-77.96%
Operating Profit (PBDIT) excl Other Income
458.58
2,535.06
-2,076.48
-81.91%
Other Income
50.42
280.86
-230.44
-82.05%
Operating Profit (PBDIT)
509.00
2,815.92
-2,306.92
-81.92%
Interest
11.20
33.53
-22.33
-66.60%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
497.80
2,782.39
-2,284.59
-82.11%
Depreciation
74.27
398.25
-323.98
-81.35%
Profit Before Tax
423.53
2,384.14
-1,960.61
-82.24%
Tax
108.63
457.58
-348.95
-76.26%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
314.90
1,926.56
-1,611.66
-83.65%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
314.90
1,926.56
-1,611.66
-83.65%
Share in Profit of Associates
0.00
15.21
-15.21
-100.00%
Minority Interest
-1.20
-28.87
27.67
95.84%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
313.70
1,912.90
-1,599.20
-83.60%
Equity Capital
45.32
40.06
5.26
13.13%
Face Value
1.00
1.00
0.00
Reserves
2,019.74
9,323.03
-7,303.29
-78.34%
Earnings per share (EPS)
6.92
47.75
-40.83
-85.51%
Diluted Earnings per share
6.92
47.68
-40.76
-85.49%
Operating Profit Margin (Excl OI)
21.06%
24.53%
0.00
-3.47%
Gross Profit Margin
22.86%
26.92%
0.00
-4.06%
PAT Margin
14.46%
18.79%
0.00
-4.33%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 2,177.41 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 17.56% vs 24.23% in Mar 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 313.70 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 17.80% vs 44.29% in Mar 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 458.58 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 35.15% vs 31.07% in Mar 2023
Annual - Interest
Interest 11.20 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 22.67% vs 8.05% in Mar 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.06%
in Mar 2024Figures in Rs %
YoY Growth in year ended Mar 2024 has improved from Mar 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
